» Articles » PMID: 39003344

Circulating Levels of Neurofilament Light Chain As a Biomarker of Infarct and White Matter Hyperintensity Volumes After Ischemic Stroke

Overview
Journal Sci Rep
Specialty Science
Date 2024 Jul 13
PMID 39003344
Authors
Affiliations
Soon will be listed here.
Abstract

Serum neurofilament light chain protein (sNfL) shows promise as a biomarker for infarct size in acute ischemic stroke and for monitoring cerebral small vessel disease (cSVD). However, distinguishing the cSVD contribution after stroke may not be possible due to post-stroke sNfL increase. Additionally, it remains unclear if etiologic subtype differences exist. We measured infarct and white matter hyperintensity (WMH) volumes using MRI at the index stroke in ischemic stroke patients (n = 316, mean age 53 years, 65% males) and at 7-year follow-up (n = 187). Serum NfL concentration was measured in the acute phase (n = 235), at 3-months (n = 288), and 7-years (n = 190) post stroke. In multivariable regression, acute and 3-month sNfL concentrations were associated with infarct volume and time since stroke, but not with stroke etiology or infarct location. Seven years post-stroke, sNfL was associated with WMHs and age, but not with stroke etiology. Nonlinear regression estimated that sNfL peaks around 1 month, and declines by 50% at 3 months, and 99% at 9 months. We conclude that sNfL can indicate infarct volume and time since brain injury in the acute and subacute phases after stroke. Due to the significant post-stroke sNfL increase, several months are needed for reliable assessment of cSVD activity.

Citing Articles

Neurological Biomarker Profiles in Royal Canadian Air Force (RCAF) Pilots and Aircrew.

Rhind S, Shiu M, Vartanian O, Allen S, Palmer M, Ramirez J Brain Sci. 2025; 14(12.

PMID: 39766495 PMC: 11674576. DOI: 10.3390/brainsci14121296.


Plasma brain-derived tau correlates with cerebral infarct volume.

Gonzalez-Ortiz F, Holmegaard L, Andersson B, Brannmark C, Blomstrand C, Zetterberg H J Intern Med. 2024; 297(2):173-185.

PMID: 39639627 PMC: 11771704. DOI: 10.1111/joim.20041.

References
1.
Khalil M, Teunissen C, Otto M, Piehl F, Sormani M, Gattringer T . Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018; 14(10):577-589. DOI: 10.1038/s41582-018-0058-z. View

2.
Gattringer T, Pinter D, Enzinger C, Seifert-Held T, Kneihsl M, Fandler S . Serum neurofilament light is sensitive to active cerebral small vessel disease. Neurology. 2017; 89(20):2108-2114. PMC: 5711505. DOI: 10.1212/WNL.0000000000004645. View

3.
Qu Y, Tan C, Shen X, Li H, Cui M, Tan L . Association of Plasma Neurofilament Light With Small Vessel Disease Burden in Nondemented Elderly: A Longitudinal Study. Stroke. 2021; 52(3):896-904. DOI: 10.1161/STROKEAHA.120.030302. View

4.
Duering M, Konieczny M, Tiedt S, Baykara E, Tuladhar A, van Leijsen E . Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden. J Stroke. 2018; 20(2):228-238. PMC: 6007291. DOI: 10.5853/jos.2017.02565. View

5.
Pinter D, Gattringer T, Enzinger C, Seifert-Held T, Kneihsl M, Fandler S . Longitudinal MRI dynamics of recent small subcortical infarcts and possible predictors. J Cereb Blood Flow Metab. 2018; 39(9):1669-1677. PMC: 6727145. DOI: 10.1177/0271678X18775215. View